Hunter Smith
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Hunter Smith
Hunter Smith is recorded as CEO and CFO at Rhythm Pharmaceuticals, Inc. (RYTM). The proxy statement of Rhythm Pharmaceuticals, Inc. reports total compensation of $6,228,429 for Hunter Smith in fiscal 2025, including a base salary of $540,477. Disclosed compensation is on record for 8 fiscal years. Hunter Smith has spoken on 21 earnings calls across 1 company, most recently for Rhythm Pharmaceuticals, Inc. on August 4, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rhythm Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- David P. Meeker, M.D. CEO, Chairman
- David Meeker Chairman
- Christophe R. Jean Board Member
- David W. J. McGirr Board Member
- Jennifer Good Board Member
- Kimberly J. Popovits Board Member
- Lynn A. Tetrault Board Member
- Stuart A. Arbuckle Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $540,477 | $6,228,429 |
| 2024 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $499,385 | $5,050,410 |
| 2023 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $476,154 | $2,308,007 |
| 2022 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $460,000 | $1,215,125 |
| 2021 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $435,957 | $2,309,413 |
| 2020 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $416,118 | $2,662,468 |
| 2019 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $393,992 | $1,922,853 |
| 2018 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer, Treasurer, Secretary and Interim President and Chief Executive Officer | $387,600 | $1,587,137 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.